RANGER MICRO CAP FUND
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
14.5%
1 yr return
27.5%
3 Yr Avg Return
8.0%
5 Yr Avg Return
3.8%
Net Assets
$11.6 M
Holdings in Top 10
34.0%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.99%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 56.25%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$250,000
IRA
$250,000
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
RFIMX - Profile
Distributions
- YTD Total Return 14.5%
- 3 Yr Annualized Total Return 8.0%
- 5 Yr Annualized Total Return 3.8%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -1.01%
- Dividend Yield 0.3%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameRANGER MICRO CAP FUND
-
Fund Family NameRanger Funds
-
Inception DateJun 06, 2018
-
Shares OutstandingN/A
-
Share ClassInstl
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerAndrew Hill
Fund Description
Principal Investment Strategies: Under normal market conditions, the Fund invests at least 80% of its assets in common stocks of micro capitalization ("micro cap") companies. The Micro Cap Growth Strategy seeks long-term growth of capital by investing primarily in common stocks of growth-oriented domestic issuers which, at the initial time of purchase are within the capitalization range of issuers represented within the Russell Microcap® Growth Index. As of the most recent reconstitution date of April 30, 2025, the market capitalization range was $30.3 million to $1.3 billion.
RIM's strategy begins by narrowing the microcap stock universe to identify companies that RIM believes have a proven track record of competitive advantages and the ability to produce sustainable value for shareholders in the foreseeable future. From this group, RIM selects securities that it believes are trading at prices below their intrinsic value. RIM sells a stock if it believes the stock is overvalued, more attractive candidates arise, or if there is a substantial, long term reduction in a company's fundamental prospects that impair its value.
RFIMX - Performance
Return Ranking - Trailing
| Period | RFIMX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 14.5% | -21.0% | 75.2% | 51.80% |
| 1 Yr | 27.5% | -22.1% | 123.6% | 58.60% |
| 3 Yr | 8.0%* | -5.4% | 37.8% | 87.40% |
| 5 Yr | 3.8%* | -8.3% | 38.7% | 55.69% |
| 10 Yr | N/A* | 4.4% | 26.8% | N/A |
* Annualized
Return Ranking - Calendar
| Period | RFIMX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 0.7% | -58.0% | 42.0% | 56.80% |
| 2024 | 11.5% | -63.4% | 62.9% | 46.00% |
| 2023 | 8.3% | -20.5% | 54.6% | 87.75% |
| 2022 | -48.9% | -82.1% | 32.2% | 97.57% |
| 2021 | -23.3% | -90.6% | 300.1% | 90.41% |
Total Return Ranking - Trailing
| Period | RFIMX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 14.5% | -21.0% | 75.2% | 51.80% |
| 1 Yr | 27.5% | -22.1% | 123.6% | 58.60% |
| 3 Yr | 8.0%* | -5.4% | 37.8% | 87.40% |
| 5 Yr | 3.8%* | -8.3% | 38.7% | 55.69% |
| 10 Yr | N/A* | 4.4% | 26.8% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | RFIMX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 2.0% | -23.5% | 42.0% | 81.60% |
| 2024 | 11.9% | -3.8% | 68.8% | 66.40% |
| 2023 | 9.1% | -19.0% | 54.6% | 88.96% |
| 2022 | -23.8% | -59.9% | 32.2% | 23.53% |
| 2021 | 31.6% | -22.7% | 411.9% | 3.06% |
NAV & Total Return History
RFIMX - Holdings
Concentration Analysis
| RFIMX | Category Low | Category High | RFIMX % Rank | |
|---|---|---|---|---|
| Net Assets | 11.6 M | 4.59 M | 42.8 B | 97.60% |
| Number of Holdings | 47 | 7 | 1223 | 92.60% |
| Net Assets in Top 10 | 3.75 M | 393 K | 3.7 B | 97.80% |
| Weighting of Top 10 | 34.02% | 9.3% | 100.0% | 17.64% |
Top 10 Holdings
- PDF Solutions, Inc. 4.19%
- Ligand Pharmaceuticals, Inc. 4.08%
- Phibro Animal Health Corp. 3.70%
- iRadimed Corp. 3.59%
- Argan, Inc. 3.25%
- Douglas Dynamics,Inc. 3.24%
- Metropolitan Bank Holding Corp. 3.21%
- Business First Bancshares, Inc. 2.99%
- UFP Technologies, Inc. 2.98%
- LeMaitre Vascular, Inc. 2.79%
Asset Allocation
| Weighting | Return Low | Return High | RFIMX % Rank | |
|---|---|---|---|---|
| Stocks | 98.37% | 90.58% | 106.14% | 50.60% |
| Cash | 1.92% | 0.00% | 33.61% | 53.40% |
| Preferred Stocks | 0.00% | 0.00% | 5.64% | 51.00% |
| Other | 0.00% | -0.55% | 6.22% | 56.00% |
| Convertible Bonds | 0.00% | 0.00% | 1.57% | 45.80% |
| Bonds | 0.00% | 0.00% | 4.40% | 46.20% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | RFIMX % Rank | |
|---|---|---|---|---|
| Technology | 30.79% | 2.91% | 75.51% | 16.00% |
| Healthcare | 29.08% | 0.00% | 47.90% | 8.60% |
| Consumer Cyclical | 14.41% | 0.00% | 24.04% | 29.80% |
| Financial Services | 9.89% | 0.00% | 42.95% | 22.00% |
| Industrials | 9.26% | 0.00% | 36.64% | 91.60% |
| Consumer Defense | 3.41% | 0.00% | 13.56% | 60.60% |
| Energy | 3.16% | 0.00% | 55.49% | 38.00% |
| Utilities | 0.00% | 0.00% | 4.68% | 60.80% |
| Real Estate | 0.00% | 0.00% | 15.31% | 85.40% |
| Communication Services | 0.00% | 0.00% | 15.31% | 91.80% |
| Basic Materials | 0.00% | 0.00% | 9.24% | 92.20% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | RFIMX % Rank | |
|---|---|---|---|---|
| US | 98.37% | 11.05% | 106.14% | 42.40% |
| Non US | 0.00% | 0.00% | 84.43% | 55.20% |
RFIMX - Expenses
Operational Fees
| RFIMX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.99% | 0.05% | 7.92% | 11.40% |
| Management Fee | 1.00% | 0.04% | 1.62% | 89.18% |
| 12b-1 Fee | 0.00% | 0.00% | 1.00% | 7.87% |
| Administrative Fee | N/A | 0.01% | 0.40% | N/A |
Sales Fees
| RFIMX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| RFIMX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| RFIMX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 56.25% | 3.00% | 264.00% | 51.48% |
RFIMX - Distributions
Dividend Yield Analysis
| RFIMX | Category Low | Category High | RFIMX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.26% | 0.00% | 6.91% | 53.40% |
Dividend Distribution Analysis
| RFIMX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annual | Annual | Annual |
Net Income Ratio Analysis
| RFIMX | Category Low | Category High | RFIMX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -1.01% | -2.47% | 1.10% | 74.49% |
Capital Gain Distribution Analysis
| RFIMX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 29, 2025 | $0.097 | CapitalGainLongTerm |
| Dec 27, 2024 | $0.022 | OrdinaryDividend |
| Dec 27, 2024 | $0.022 | CapitalGainShortTerm |
| Dec 27, 2023 | $0.049 | CapitalGainLongTerm |
| Dec 28, 2022 | $2.874 | CapitalGainLongTerm |
| Dec 28, 2021 | $8.450 | OrdinaryDividend |
| Dec 28, 2018 | $0.031 | CapitalGainShortTerm |
RFIMX - Fund Manager Analysis
Managers
Andrew Hill
Start Date
Tenure
Tenure Rank
Jun 06, 2018
3.99
4.0%
Mr. Hill joined Ranger in 2003 and currently serves as a Portfolio Manager. His primary research focus is on financial services, oil and gas, and energy. Prior to joining the Ranger team in 2003, Mr. Hill served as a Research Analyst for Ranger Capital affiliated investment funds. Mr. Hill earned a B.A degree (Phi Beta Kappa) in Economics from Vanderbilt University in 1996.
W. Doenges
Start Date
Tenure
Tenure Rank
Jun 06, 2018
3.99
4.0%
Conrad Doenges joined Ranger Investments Management, L.P. in 2004 and serves as a Portfolio Manager. Mr. Doenges served as a Partner, Managing Director and Co-Chief Investment Officer of John McStay Investment Counsel. Mr. Doenges was employed by John McStay Investment Counsel between 1998 and 2004 and throughout his tenure was responsible for portfolio management, research, new business development and client service. Between 1996 and 1998, Mr. Doenges served as President of Newcastle Capital Management, a boutique investment research firm that serviced clients including Friess Associates and John McStay Investment Counsel. From 1991 to the time he established Newcastle Capital Management, Mr. Doenges worked as an analyst for Friess Associates. Between 1988 and 1991 Mr. Doenges served as an associate with Nations Bank (later renamed Bank of America). Mr. Doenges graduated from Davidson College with a B.A. degree in History.
Joseph LaBate
Start Date
Tenure
Tenure Rank
Jun 06, 2018
3.99
4.0%
Mr. LaBate joined Ranger in 2002 and currently serves as a Portfolio Manager. His primary research focus is on healthcare, producer durables and materials. Prior to joining Ranger, Mr. LaBate served as a Portfolio Manager for RedHawk Advisors LLC and conducted fundamental equity research with a focus on small-cap healthcare securities. Mr. LaBate earned a B.S. degree in Finance (Cum Laude) from Siena College in 1996 and an M.B.A. degree from Southern Methodist University in 2002.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.08 | 30.44 | 9.26 | 5.25 |